Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database

1. Morice, P.-M.
2. Leary, A.
3. Dolladille, C.
4. Chrétien, B.
5. Poulain, L.
6. González-Martín, A.
7. Moore, K.
8. O'Reilly, E.M.
9. Ray-Coquard, I.
10. Alexandre, J.